MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Pilot - Peri-operative Beta Blockade

Phase 4
Completed
Conditions
Troponin Levels
Adrenergic Beta-Receptor Blockader
Cardiomyopathy, Post-surgical
Interventions
First Posted Date
2016-04-21
Last Posted Date
2020-01-30
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
70
Registration Number
NCT02746575
Locations
🇺🇸

Barnes-Jewish Hospital/Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings

Not Applicable
Completed
Conditions
Fetal Hypoxia
Fetal-Placental Circulation
Electronic Fetal Monitoring
Interventions
First Posted Date
2016-04-18
Last Posted Date
2021-11-26
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
114
Registration Number
NCT02741284
Locations
🇺🇸

Barnes Jewish Hospital, Saint Louis, Missouri, United States

Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy

Not Applicable
Completed
Conditions
Cancer
Patient Fall
Geriatric Disorder
Interventions
Other: Stepping On Education Program
Other: Home visit
Other: Patient Questionnaire
Other: Mini-Balance Evaluation Systems Test
Other: GAITRite
Other: Precise measure of movement testing
First Posted Date
2016-04-14
Last Posted Date
2020-10-14
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
101
Registration Number
NCT02737839
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Exome Sequencing for Atypical Femoral Fractures

Completed
Conditions
Atypical Femoral Fractures
Bisphosphonate Therapy
Osteoporosis
Interventions
Drug: Bisphosphonate
First Posted Date
2016-04-07
Last Posted Date
2018-12-31
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
38
Registration Number
NCT02731040

Worksite Phone Counseling for Smoking Cessation

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Directive smoking cessation coaching
Behavioral: Nondirective smoking cessation coaching
First Posted Date
2016-04-06
Last Posted Date
2016-12-23
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
518
Registration Number
NCT02730260
Locations
🇺🇸

Washington University School of Medicine, St. Louis, Missouri, United States

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

Phase 1
Completed
Conditions
Mantle Cell Lymphoma
Interventions
Drug: Bendamustine
Drug: Rituximab
Drug: Cytarabine
Drug: Pegfilgrastim
Procedure: Leukapheresis
Drug: Filgrastim
Procedure: Autologous stem cell transplant
First Posted Date
2016-04-05
Last Posted Date
2023-11-01
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
18
Registration Number
NCT02728531
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy

Phase 1
Completed
Conditions
Vasculopathy, Retinal, With Cerebral Leukodystrophy
Cerebroretinal Vasculopathy, Hereditary
Interventions
First Posted Date
2016-03-30
Last Posted Date
2020-11-19
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
4
Registration Number
NCT02723448
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Implementation of Evidence Based Practices for Colonoscopy: The Strategies to Improve Colonoscopy Study

Not Applicable
Completed
Conditions
Colonoscopy
Interventions
Behavioral: Staff multi-component implementation strategy
First Posted Date
2016-03-30
Last Posted Date
2017-01-10
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
46184
Registration Number
NCT02723370

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Phase 1
Completed
Conditions
Solid Tumor, Adult
Interventions
Radiation: Fludeoxyglucose F 18
Device: Positron Emission Tomography
Device: Computerized Tomography
Device: Magnetic Resonance Imaging
First Posted Date
2016-03-23
Last Posted Date
2019-04-05
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
19
Registration Number
NCT02717572
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase 1
Active, not recruiting
Conditions
Glioblastoma Multiforme
Interventions
Drug: Disulfiram
Drug: Copper Gluconate
Procedure: Surgery
Radiation: Radiation
Drug: Temozolomide
First Posted Date
2016-03-22
Last Posted Date
2024-07-29
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
35
Registration Number
NCT02715609
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath